ConductScience.org, home

Paper1233232

Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses.

Eichelbaum M and 4 others. Eur J Clin Pharmacol, 1975. Cited by 215 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Papers, record 1233232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1233232

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1975
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
215
iCite
Relative citation ratio, by iCite
12.8
iCite
Revised in PubMed
2019-08-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eichelbaum MM
2Ekbom KK
3Bertilsson LL
4Ringberger VAV A
5Rane AA

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarbamazepineMajor topic
Drug Administration Schedule
Epoxy Compounds
Half-Life
Humans
Kinetics
Male
Middle Aged

Source PubMed

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,652,110Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.J Pharm Sci1968https://conductscience.org/library/papers/5652110PubMed
2971,704Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.Eur J Clin Pharmacol1976https://conductscience.org/library/papers/971704PubMed
34,207,990Carbamazepine for epilepsy. A controlled prospective evaluation.Neurology1974https://conductscience.org/library/papers/4207990PubMed
45,044,818Mass spectrometric characterization of carbamazepine-10,11-epoxide, a carbamazepine metabolite isolated from human urine.J Pharm Sci1972https://conductscience.org/library/papers/5044818PubMed
55,884,654Blood levels of drug at the equilibrium state after multiple dosing.Nature1965https://conductscience.org/library/papers/5884654PubMed
65,015,597Carbamazepine in the treatment of tabetic lightning pains.Arch Neurol1972https://conductscience.org/library/papers/5015597PubMed
74,521,093Concentration of carbamazepine (Tegretol) in serum and in cerebrospinal fluid in patients with epilepsy.Epilepsia1973https://conductscience.org/library/papers/4521093PubMed
84,580,994Quantitative determination of carbamazepine in plasma by mass fragmentography.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4580994PubMed
91,117,034Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatography.J Chromatogr1975https://conductscience.org/library/papers/1117034PubMed
104,773,786Influence of phenobarbital and diphenylhydantoin on plasma carbamazepine levels in patients with epilepsy.Acta Neurol Scand1973https://conductscience.org/library/papers/4773786PubMed
114,804,149A micromethod for the determination of carbamazepine in blood by high speed liquid chromatography.Z Klin Chem Klin Biochem1973https://conductscience.org/library/papers/4804149PubMed
121,233,212Distribution and elimination kinetics of carbamazepine in man.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/1233212PubMed

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 215 citations.

PMIDTitleJournalYearIn PapersSource
40,316,811Establishing Clinically Relevant Specifications for Carbamazepine Tablets Using Physiologically Based Pharmacokinetic Modeling.AAPS J2025https://conductscience.org/library/papers/40316811PubMed
39,846,525ABCB1 Polymorphism Is Associated with Higher Carbamazepine Clearance in Children.Pediatr Rep2025https://conductscience.org/library/papers/39846525PubMed
36,114,834Use of a long-acting substitute in detoxification from benzodiazepines: safety (accumulation) problems and proposed mitigation procedure.Eur J Clin Pharmacol2022https://conductscience.org/library/papers/36114834PubMed
28,064,419Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children.Eur J Drug Metab Pharmacokinet2017https://conductscience.org/library/papers/28064419PubMed
25,982,590Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy.Epilepsia2015https://conductscience.org/library/papers/25982590PubMed
24,312,049Effects of antiepileptic drugs on hippocampal neurons coupled to micro-electrode arrays.Front Neuroeng2013https://conductscience.org/library/papers/24312049PubMed
23,252,947Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.Pharmacogenomics2013https://conductscience.org/library/papers/23252947PubMed
23,096,427Enhanced clearance of carbamazepine using albumin-containing dialysate during CVVHDF.Intensive Care Med2013https://conductscience.org/library/papers/23096427PubMed
22,278,332Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.Clin Pharmacol Ther2012https://conductscience.org/library/papers/22278332PubMed
21,107,923Diseases affecting bone quality: beyond osteoporosis.Clin Orthop Relat Res2011https://conductscience.org/library/papers/21107923PubMed
19,566,114Characterization of the time course of carbamazepine deinduction by an enzyme turnover model.Clin Pharmacokinet2009https://conductscience.org/library/papers/19566114PubMed
17,532,712Simulated fluctuations in plasma drug concentrations for patients receiving oxcarbazepine or carbamazepine extended-release capsules.Clin Drug Investig2005https://conductscience.org/library/papers/17532712PubMed
14,754,583Incorporating children's toxicokinetics into a risk framework.Environ Health Perspect2004https://conductscience.org/library/papers/14754583PubMed
9,114,913Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients.Br J Clin Pharmacol1993https://conductscience.org/library/papers/9114913PubMed
8,877,250Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.Clin Pharmacokinet1996https://conductscience.org/library/papers/8877250PubMed
8,853,934Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.Clin Pharmacokinet1996https://conductscience.org/library/papers/8853934PubMed
8,471,190Carbamazepine overdose. Features of 33 cases.Drug Saf1993https://conductscience.org/library/papers/8471190PubMed
7,875,188Early stage autoinduction of carbamazepine metabolism in humans.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/7875188PubMed
7,248,139Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7248139PubMed
7,082,531Saliva carbamazepine levels in children before and during multiple dosing.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7082531PubMed

See all 56 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1233232

GET https://conductscience.org/api/papers/v1/1233232/cited_by?page=2